TAF II p20 Activators comprise a diverse set of chemical compounds that indirectly bolster the functional activity of TAF II p20, primarily by modulating various cellular signaling pathways and altering transcriptional dynamics. Forskolin and IBMX, for example, enhance intracellular cAMP levels, leading to the persistent activation of PKA, which in turn can increase the phosphorylation of proteins involved in the transcription initiation complex, thus potentiating the activity of TAF II p20 in the early stages of mRNA synthesis. Similarly, Theophylline and Rolipram, acting as phosphodiesterase inhibitors, sustain elevated levels of cAMP, resulting in the activation of PKA and an indirect amplification of TAF II p20's role in transcription. Sodium Butyrate, Trichostatin A, and SAHA, by inhibiting histone deacetylases, foster a more relaxed chromatin structure, which may facilitate the recruitment and stabilization of TAF II p20 at promoter regions, thereby promoting transcription initiation.
Histone acetylation state modifications by compounds such as Epigallocatechin gallate and Retinoic Acid can also create a transcriptionally permissive environment that is conducive to TAF II p20 activity. Epigallocatechin gallate's inhibition of DNA methyltransferases and Retinoic Acid's influence on gene expression through retinoic acid receptors could both lead to enhanced recruitment of TAF II p20 to responsive promoters. On another front, PMA, as a PKC activator, can phosphorylate transcription-related proteins, providing a potential boost to TAF II p20 activity. Moreover, the availability of nucleotide pools, as ensured by compounds like CTP, is critical for the efficient function of RNA polymerase II, with which TAF II p20 interacts, underscoring the importance of nucleotide availability in transcription initiation. Collectively, these activators, through their targeted effects on cellular signaling and chromatin dynamics, facilitate the enhancement of TAF II p20's involvement in transcription initiation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a labdane diterpenoid with adenylate cyclase activating properties. By increasing cAMP levels, it enhances the activity of PKA, which can phosphorylate the transcription factor complexes including those involving TAF II p20, enhancing its role in the initiation of gene transcription. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases. By preventing cAMP degradation, it indirectly maintains PKA activation which can lead to increased phosphorylation and activity of TAF II p20 within the transcription machinery. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor. It alters chromatin structure and increases transcription factor accessibility to DNA, potentially enhancing TAF II p20's role in the assembly of the transcriptional machinery at promoter regions. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor. It increases acetylation of histones, facilitating a more open chromatin conformation and potentially enhancing TAF II p20-mediated transcription initiation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. It leads to hypomethylation of DNA and is thought to enhance transcription factor access to DNA, thereby potentially enhancing TAF II p20 function in transcription initiation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin present in green tea with multiple cellular effects, including inhibition of DNA methyltransferases. It may indirectly enhance the activity of TAF II p20 by promoting a transcriptionally permissive chromatin state. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid (SAHA) is a potent histone deacetylase inhibitor. By increasing the acetylation of histones, it can enhance the recruitment of TAF II p20 to promoters, facilitating transcription initiation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a metabolite of Vitamin A that regulates gene expression through retinoic acid receptors. It may enhance the recruitment of TAF II p20 to promoters of genes responsive to retinoic acid. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC can phosphorylate proteins involved in transcription regulation, potentially enhancing the functional activity of TAF II p20. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline is a phosphodiesterase inhibitor, which increases intracellular cAMP levels. This elevation can activate PKA, which may enhance TAF II p20 activity in the transcription initiation complex. | ||||||